A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Clinical trial NCT06789445 · RECRUITING

Trial details

NCT number: NCT06789445
Sponsor: BlueRock Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Photoreceptor Disease Retinitis Pigmentosa (RP)Usher Syndrome Inherited Retinal Disease (IRD)Rod-Cone Dystrophy Rod-Cone Disease Retinal Degeneration Cone-Rod Disease (C-RD)Cone-Rod Dystrophy

Start date: 2025-03-10
Primary completion: 2029-10-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.